Recurrent and New diagnosis of Fatty Liver Disease Following Liver Transplant

The rates of fatty liver (NAFLD) are rising rapidly and it is predicted to become the most common cause for liver transplant. Following transplant recurrence of NAFLD is common; 60% of patients have recurrence at 1-year post transplant and 80% at 5-years post transplant.
Despite being common and affecting a large number of patients we still don't know all of the risk factors associated with recurrent or a new diagnosis of NAFLD following transplant. We also don't know what impact this disease has following transplant.
The aim of this study is to study the incidence, risk factors, natural history and outcomes in patients with recurrent and de novo NAFLD following liver transplant.

null

Study Sponsored By

University of Alberta

Participants Required

More Information

Study ID: Pro00104902